Age-associated comorbidities (cardiovascular and renal disease) were more prevalent
among HIV-positive compared with HIV-uninfected patients. Comorbidity was associated with …

Background miR-122 is an important host factor for hepatitis C virus (HCV) replication. The
aim of this study was to assess the safety and tolerability, pharmacokinetics, and antiviral …

Objective We assessed the effectiveness and safety of daclatasvir (DCV) plus sofosbuvir (SOF),
with or without ribavirin (RBV), in a large real-world cohort, including patients with …

Since the advent of direct‐acting antivirals, elimination of hepatitis C viral (HCV) infections
seems within reach. However, studies on the HCV cascade of care show suboptimal …

Background Protease inhibitor-containing antiretroviral therapy for the treatment of HIV-1
infection is associated with elevated triglyceride and low-density lipoprotein (LDL)-cholesterol …

Background Mortality rates are high among hospitalized patients with COVID-19, especially
in those intubated on the ICU. Insight in pathways associated with unfavourable outcome …

All-oral direct-acting antiviral drugs (DAAs) for hepatitis C virus, which have response rates
of 95% or more, represent a major clinical advance. However, the high list price of DAAs has …

There are no comprehensive data on viral hepatitis from Sierra Leone; however, a huge
disease burden has been observed in different subpopulations. This review summarizes …

… Marc van der Valk has received consultancy fees through his institution from Abbvie, Janssen,
MSD, ViiV, Gilead and unrestricted research support from Abbvie, Janssen, MSD, Gilead. …

Background: Frailty is an age-related syndrome of decreased physiological reserve and
resistance to stressors, associated with increased morbidity and mortality in the general elderly …